Literature DB >> 27367467

Assessment of Solvated Interaction Energy Function for Ranking Antibody-Antigen Binding Affinities.

Traian Sulea1, Victor Vivcharuk1, Christopher R Corbeil1, Christophe Deprez1, Enrico O Purisima1.   

Abstract

Affinity modulation of antibodies and antibody fragments of therapeutic value is often required in order to improve their clinical efficacies. Virtual affinity maturation has the potential to quickly focus on the critical hotspot residues without the combinatorial explosion problem of conventional display and library approaches. However, this requires a binding affinity scoring function that is capable of ranking single-point mutations of a starting antibody. We focus here on assessing the solvated interaction energy (SIE) function that was originally developed for and is widely applied to scoring of protein-ligand binding affinities. To this end, we assembled a structure-function data set called Single-Point Mutant Antibody Binding (SiPMAB) comprising several antibody-antigen systems suitable for this assessment, i.e., based on high-resolution crystal structures for the parent antibodies and coupled with high-quality binding affinity measurements for sets of single-point antibody mutants in each system. Using this data set, we tested the SIE function with several mutation protocols based on the popular methods SCWRL, Rosetta, and FoldX. We found that the SIE function coupled with a protocol limited to sampling only the mutated side chain can reasonably predict relative binding affinities with a Spearman rank-order correlation coefficient of about 0.6, outperforming more aggressive sampling protocols. Importantly, this performance is maintained for each of the seven system-specific component subsets as well as for other relevant subsets including non-alanine and charge-altering mutations. The transferability and enrichment in affinity-improving mutants can be further enhanced using consensus ranking over multiple methods, including the SIE, Talaris, and FOLDEF energy functions. The knowledge gained from this study can lead to successful prospective applications of virtual affinity maturation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27367467     DOI: 10.1021/acs.jcim.6b00043

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  12 in total

Review 1.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

2.  An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.

Authors:  Johnathan D Guest; Thom Vreven; Jing Zhou; Iain Moal; Jeliazko R Jeliazkov; Jeffrey J Gray; Zhiping Weng; Brian G Pierce
Journal:  Structure       Date:  2021-02-03       Impact factor: 5.871

3.  Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences.

Authors:  Christopher R Corbeil; Mahder Seifu Manenda; Traian Sulea; Jason Baardsnes; Marie-Ève Picard; Hervé Hogues; Francis Gaudreault; Christophe Deprez; Rong Shi; Enrico O Purisima
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.996

4.  A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies.

Authors:  Kevin A Henry; Traian Sulea; Henk van Faassen; Greg Hussack; Enrico O Purisima; C Roger MacKenzie; Mehdi Arbabi-Ghahroudi
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

5.  Determination of equilibrium dissociation constants for recombinant antibodies by high-throughput affinity electrophoresis.

Authors:  Yuchen Pan; Eric K Sackmann; Karolina Wypisniak; Michael Hornsby; Sammy S Datwani; Amy E Herr
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

6.  Assisted Design of Antibody and Protein Therapeutics (ADAPT).

Authors:  Victor Vivcharuk; Jason Baardsnes; Christophe Deprez; Traian Sulea; Maria Jaramillo; Christopher R Corbeil; Alaka Mullick; Joanne Magoon; Anne Marcil; Yves Durocher; Maureen D O'Connor-McCourt; Enrico O Purisima
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

7.  Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment.

Authors:  Traian Sulea; Nazanin Rohani; Jason Baardsnes; Christopher R Corbeil; Christophe Deprez; Yuneivy Cepero-Donates; Alma Robert; Joseph D Schrag; Marie Parat; Mélanie Duchesne; Maria L Jaramillo; Enrico O Purisima; John C Zwaagstra
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

8.  Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody.

Authors:  Traian Sulea; Greg Hussack; Shannon Ryan; Jamshid Tanha; Enrico O Purisima
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  Genomic screening of new putative antiviral lectins from Amazonian cyanobacteria based on a bioinformatics approach.

Authors:  Andrei Santos Siqueira; Alex Ranieri Jerônimo Lima; Delia Cristina Figueira Aguiar; Alberdan Silva Santos; João Lídio da Silva Gonçalves Vianez Júnior; Evonnildo Costa Gonçalves
Journal:  Proteins       Date:  2018-09-25

10.  Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates.

Authors:  John C Zwaagstra; Traian Sulea; Jason Baardsnes; Stevo Radinovic; Yuneivy Cepero-Donates; Alma Robert; Maureen D O'Connor-McCourt; Ilia A Tikhomirov; Maria Luz Jaramillo
Journal:  PLoS One       Date:  2019-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.